INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2014

Higher dietary polyphenol consumption was linked to lower all-cause mortality in high-risk individuals.

Investigators examined data from 7,447 participants in the PREDIMED trial followed for an average of 4.8 years, recording 327 deaths. Comparing the highest to lowest quintiles of total polyphenol intake was linked to a reduced risk of all-cause mortality (HR 0.63; 95% CI 0.41 to 0.97; P for trend = 0.12). Among subclasses, stilbenes (HR 0.48; 95% CI 0.25 to 0.91) and lignans (HR 0.60; 95% CI 0.37 to 0.97) were inversely associated with mortality.

Study type
Secondary analysis of a randomized controlled trial
Who was studied
7,447 participants at high cardiovascular risk in the PREDIMED trial
What was measured
All-cause mortality

THE PAPER

Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial.

Tresserra-Rimbau A, Rimm EB, Medina-Remón A, Martínez-González MA, López-Sabater MC, Covas MI, Corella D, Salas-Salvadó J, Gómez-Gracia E, Lapetra J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Muñoz MA, Gea A, Ruiz-Gutiérrez V, Estruch R, Lamuela-Raventós RM, PREDIMED Study Investigators. BMC Med, 2014.

PubMed 24886552 ↗DOI 10.1186/1741-7015-12-77 ↗

Heart & arteriesNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.